Skip to main content
AFK Sistema logo

AFK Sistema — Investor Relations & Filings

Ticker · AFKS ISIN · US48122U1051 LEI · 213800JSZ2UUK4QQK694 MOEX Administrative and support service activities
Open in API
Filings indexed 444 across all filing types
Latest filing 2021-02-20 Capital/Financing Update
Country RU Russian Federation
Listing MOEX AFKS

About AFK Sistema

https://sistema.com/

AFK Sistema is a large, publicly-traded diversified holding company and a major private investor. The corporation manages a portfolio of assets across a wide range of sectors, including telecommunications, healthcare, agriculture, forestry, and fisheries. The company focuses on the strategic development and operational efficiency of its portfolio companies. A key element of its strategy is the implementation of digital solutions and advanced technologies to drive growth and innovation, with a notable emphasis on digital agrotech and the digitalization of healthcare services to improve quality and accessibility.

Recent filings

Filing Released Lang Actions
Sistema PJSFC: Sistema closes order book on RUB 17.5 bn series 001P-18 and 001P-19 exchange-traded bonds
Capital/Financing Update Classification · 98% confidence The document announces the successful closing of the order book for two series of exchange-traded bonds (series 001P-18 and 001P-19), detailing the coupon rates, term to maturity, and intended use of proceeds (refinancing debt). This clearly relates to the company's fundraising and capital structure activities. This fits the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory announcement (RNS), as it concerns a specific financing event.
2021-02-20 English
Sistema PJSFC: Joint venture of Sistema and Sber increases stake in JSC Elektrozavod
M&A Activity Classification · 99% confidence The document is a short announcement disseminated via EQS News Service, explicitly stating it contains 'inside information according to REGULATION (EU) No 596/2014 (MAR)'. It details a specific corporate transaction: a joint venture increasing its stake in JSC Elektrozavod. This is not a comprehensive annual report (10-K), an earnings release (ER), or a quarterly report (IR). It is a specific, material corporate event disclosure. Since it is a regulatory announcement that doesn't fit the specific categories like M&A (TAR) or Share Issue (SHA), and it is a formal disclosure of inside information, it best fits the general 'Regulatory Filings' category (RNS) as a catch-all for mandatory market disclosures that aren't the primary financial reports or specific corporate actions like dividends or director dealings. Given the length (under 5,000 characters) and the nature of disseminating information, RNS is appropriate, although TAR might be considered if the focus was purely on the acquisition structure, but RNS covers general regulatory dissemination.
2021-02-19 English
Sistema PJSFC: Sistema and RDIF agree to jointly develop Binnopharm Group
M&A Activity Classification · 99% confidence The document is a press release dated 19-Feb-2021 announcing that Sistema and RDIF have agreed to jointly develop Binnopharm Group, detailing the consolidation of pharmaceutical assets. It is explicitly labeled as 'Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR)'. This type of announcement, which details a significant corporate transaction (M&A/restructuring) and is disseminated via a regulatory news service (EQS), does not fit neatly into the specific categories like 10-K, ER, or IP. Since it is a general regulatory announcement that doesn't fit a more specific corporate action code (like TAR for M&A activity, which usually implies a formal offer or definitive agreement rather than a strategic development announcement), the most appropriate fallback category for a general regulatory news service dissemination is RNS.
2021-02-19 English
Sistema PJSFC: Director/PDMR Transaction
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them' concerning a 'Director/PDMR Transaction' involving the sale of global depositary receipts by Mr. Alexey Katkov, a Member of the Management Board. This type of filing, detailing personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing.
2021-02-17 English
Sistema PJSFC: Sistema completes secondary placement of series 001P-07 bonds
Capital/Financing Update Classification · 99% confidence The document announces the completion of a secondary placement of exchange-traded bonds (series 001P-07) by Sistema PJSFC, detailing the amount repurchased, placement price, maturity, and coupon rate. This activity directly relates to the company's financing structure and capital raising/management. This fits the definition of 'Capital/Financing Update' (CAP). Although it is a regulatory announcement ('Dissemination of a Regulatory Announcement'), the core content is a specific financing event, making CAP more precise than the general RNS fallback. The document is short and acts as a direct announcement, not a comprehensive report.
2021-02-03 English
Sistema PJSFC: Ad-Hoc Notice
M&A Activity Classification · 99% confidence The document is titled 'Ad-Hoc Notice' and is disseminated as a 'Regulatory Announcement' containing inside information under MAR. The core content announces that Sistema is preparing a portfolio company (Segezha Group) for a potential IPO, subject to market conditions, but explicitly states that 'No formal decision regarding the IPO of Segezha Group has been taken.' This is a material, non-public event disclosure that doesn't fit neatly into standard periodic reports (10-K, IR) or specific corporate actions (DIV, SHA). Since it is an announcement of a potential future transaction (IPO preparation) and is classified as an Ad-Hoc Notice under EU regulations (MAR), it functions as a general regulatory disclosure. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for general, ad-hoc regulatory disclosures that are not covered by more specific categories like M&A (TAR) or Capital Changes (CAP), as this is an announcement about *preparation* for a potential future event, not the event itself.
2021-01-18 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.